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Biological iron is necessary for vital functions and also potentially
toxic to the organisms. This dual effect raised the interest of many
investigators to study the mechanisms controlling its homeosta-
sis that are altered in many pathologic conditions. Recently the
understanding of iron metabolism significantly improved with
the discovery of genes responsible for genetic disorders, such as
hemochromatosis, the IRE/IRPs machinery and the hepcidin-
ferroportin axis, which allowed to elucidate the basis of cellular
and systemic iron homeostasis. In addition, these advances dis-
closed a causal link between deregulation of iron homeostasis,
inflammation and oxidative stress, often induced by the iron
accumulation that is commonly observed in many pathologic
conditions.
Hence, believing this was time to provide a current state-of-
the-art on the importance of iron in pathophysiologic conditions,
we thought to promote a Research Topic with the contribu-
tion of top-leading scientists who studied the effects of iron
homeostasis disruption on the outcome of genetic, inflamma-
tory, infectious, cardiovascular, and neurodegenerative diseases.
Encountering an interest even larger than our ambitions, we
successfully collected 42 manuscripts, which cover the major
aspects of iron metabolism, from the essential role of iron for
cell survival to its contribution in the pathogenesis of vari-
ous disorders. They have been organized in an e-book in 7
sections.
The first section of the Research Topic includes 11 papers
that cover the importance of iron in cellular proliferation, dif-
ferentiation and functioning, and its crucial role in essential
processes such as oxygen transport, DNA synthesis, metabolic
energy and cellular respiration. They describe the expression
and regulation of the main players involved in the mechanisms
of iron absorption, recycling, and mobilization (Zhang et al.,
2014), the cooperation among different cellular compartments
that facilitates iron mobilization/storage and prevents the dele-
terious effects induced by its accumulation, the role of iron in
the Fenton chemistry and its effects on oxidative stress and pro-
grammed cell death. Of interest is the study of the different types
of circulating iron and the strategies more commonly used for
its detection (Cabantchik, 2014). The papers also present updates
on iron metabolism in zebrafish, in C. elegans, the role of iron in
the skin and the regulatory mechanisms devoted to iron uptake,
recycling and mobilization. Altogether they provide the infor-
mation for a better understanding of the iron involvement in
pathophysiologic conditions.
The second section includes three papers dealing with the
role of heme inside cells and its cytotoxicity when it is released
from hemoproteins. In fact, most body iron is contained within
the protoporphyrin ring that acts as prosthetic group in many
hemoproteins essential to cellular functions. The different aspects
related to heme synthesis, intracellular trafficking, scavenging
and catabolism are reviewed together with the protective mech-
anisms that cooperate to prevent the deleterious effects induced
by heme accumulation and the pathological conditions in which
heme plays a dominant role (Chiabrando et al., 2014). The
expression and regulation of the main heme scavengers and trans-
porters identified are also reviewed, together with the notion
that maintenance of heme homeostasis is essential to prevent
the deleterious effect induced by its overload (Korolnek and
Hamza, 2014). The following sections are devoted to describe
how disruption of iron homeostasis is associated with a series
of syndromes and dictates the outcomes and severity of these
disorders.
The third section deals with hemochromatosis, the genetic dis-
ease that has a fundamental importance for identifying the actors
responsible for systemic iron regulation. It includes two reviews
on the origin and genetic mutations characterizing this pathology
as well as the incidence and different types of hemochromato-
sis identified so far (Vujic, 2014). The symptoms and mani-
festations that characterize these disorders and the alteration
of the responsible proteins are also described (Silvestri et al.,
2014).
The forth section deals with anemia and iron deficiency, prob-
lems that are common worldwide, and includes four papers. The
distribution of iron deficiency in the population and in partic-
ular during aging are reviewed (Busti et al., 2014). The etiology
of anemia, caused by genetic disorders, inflammation, infections,
bleeding due to the development of ulcers, drug administra-
tion or cancers are covered. The roles of TMPRSS6 and of its
substrate, hemojuvelin, in the regulation of BMP signaling and
hepcidin expression are reviewed (Core et al., 2014; Wang et al.,
2014). Finally, the increasing number of therapeutic approaches
targeting the various steps involved in hepcidin regulation are
summarized together with the promising results capable to cor-
rect altered hematological parameters in animal models (Poli
et al., 2014).
The fifth section deals with one of the hottest topics of
the field, which is the connection between iron and inflam-
mation, largely mediated by hepcidin expression. Seven papers
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are included. One is an updated review on the known bat-
tle between host and pathogen for access to the iron neces-
sary for proliferation, particular reference to the very complex
malaria infection (Spottiswoode et al., 2014). The molecular
mechanisms leading to disruption of iron homeostasis upon
infections caused by parasites (Penha-Goncalves et al., 2014),
intracellular or extracellular pathogens are also detailed (Nairz
et al., 2014). Of importance are the effects of iron supplemen-
tation therapy to individuals suffering from infectious diseases
(Clark et al., 2014) and the role of proteins that restricting
iron availability to microbes may modify the outcome of the
infection.
The sixth section discusses the role of iron overload in car-
diovascular diseases, which includes six papers. One is a review
on the long-standing and obscure relationship between iron
availability and anthracycline cardiotoxicity, stressing the role
of chelating agents and ferritins as agents protecting against
the pro-oxidant activity of the drug (Gammella et al., 2014). A
detailed overview on the pathways leading to the disruption of
iron homeostasis and impairing heart functioning is described
(Basuli et al., 2014). The toxicity of iron was addressed in dif-
ferent cell types, emphasizing in particular the effects exerted on
macrophages for the development and progression of atheroscle-
rotic plaque. In this section, a special attention is also given
to the occurrence of cardiovascular abnormalities and death
in hemochromatosis patients, thus further confirming the role
of iron in the pathogenesis of these diseases (Vinchi et al.,
2014).
Finally, the seventh section discusses the role of iron in
neurodegenerative diseases and includes nine papers. Although
the regulation of iron homeostasis in the brain remains rather
obscure, its alteration has been observed in a variety of brain dis-
orders, including Parkinson’s, Alzheimer’s, Huntington’s, Prion
and neurodegeneration with brain iron accumulation (NBIA).
This stimulated many studies to verify if the local iron overload
is one, or the main contributor to neuronal death (Wong and
Duce, 2014). The pathogenic mechanisms leading to neurode-
generation that are associated to gene mutations of NBIAs are
reviewed and they pose another tight connection between iron
deregulation and oxidative damage (Levi and Finazzi, 2014), The
involvement of inflammation in the establishment and progres-
sion of these pathologic conditions and its correlation to the
disruption of iron homeostasis was also addressed (Urrutia et al.,
2014). The beneficial effect of an oral iron chelator able to pass
through the blood-brain barrier, the deferiprone, in scavenging
excess iron from regional foci of siderosis is reviewed together
with the ongoing clinical trials. The chelator is claimed to be able
to relocate efficiently iron and to replenish iron-deprived regions,
thus ameliorating the symptoms of iron maldistribution and sup-
pressing the deleterious effects of its overload (Cabantchik et al.,
2013).
In summary, this research topic enjoys the con-
tribution of top-leading scientists aimed at providing
a current state of the art on the importance of iron
metabolism and its contribution in a variety of human
disorders.
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